Additionally, epigenetic changes such as decreased DNA methylation of the SLC6A4 promoter in patients with depression and epilepsy may increase serotonin transporter levels, potentially worsening mood symptoms [107,108]. This evidence concerns the gene SLC6A4 and major depressive disorder.